Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RRHYTHM PHARMACEUTICALS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

RHYTHM PHARMACEUTICALS, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $71.26M. Net result −$49.3M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $71.26M. Running result $71.26M. License: $0. Product: $71.26M.
  • Cost of revenue: −$8.93M. Running result $62.32M.
  • Gross profit: $62.32M. Running result $62.32M.
  • Research and development: −$43.43M. Running result $18.9M.
  • Selling, general, and administrative: −$67.45M. Running result −$48.55M.
  • Operating income: −$48.55M. Running result −$48.55M.
  • Other expense: −$302K. Running result −$48.85M.
  • Pre-tax loss: −$48.85M. Running result −$48.85M.
  • Income tax expense: −$444K. Running result −$49.3M.
  • Net loss: −$49.3M. Running result −$49.3M.